These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15123889)

  • 21. Development of Bile Salt-Resistant Leuconostoc citreum by Expression of Bile Salt Hydrolase Gene.
    Cho SK; Lee SJ; Shin SY; Moon JS; Li L; Joo W; Kang DK; Han NS
    J Microbiol Biotechnol; 2015 Dec; 25(12):2100-5. PubMed ID: 26282688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probiotic BSH Activity and Anti-Obesity Potential of
    Huang CH; Ho CY; Chen CT; Hsu HF; Lin YH
    Prev Nutr Food Sci; 2019 Dec; 24(4):434-441. PubMed ID: 31915639
    [No Abstract]   [Full Text] [Related]  

  • 23. Thermodynamic and solution state NMR characterization of the binding of secondary and conjugated bile acids to STARD5.
    Létourneau D; Lorin A; Lefebvre A; Cabana J; Lavigne P; LeHoux JG
    Biochim Biophys Acta; 2013 Nov; 1831(11):1589-99. PubMed ID: 23872533
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Yamasaki M; Minesaki M; Iwakiri A; Miyamoto Y; Ogawa K; Nishiyama K; Tsend-Ayush C; Oyunsuren T; Li Y; Nakano T; Takeshita M; Arima Y
    Food Sci Nutr; 2020 Nov; 8(11):6164-6173. PubMed ID: 33282267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicity and intracellular accumulation of bile acids in sandwich-cultured rat hepatocytes: role of glycine conjugates.
    Chatterjee S; Bijsmans IT; van Mil SW; Augustijns P; Annaert P
    Toxicol In Vitro; 2014 Mar; 28(2):218-30. PubMed ID: 24211540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IS30-related transposon mediated insertional inactivation of bile salt hydrolase (bsh1) gene of Lactobacillus plantarum strain Lp20.
    Kumar R; Grover S; Kaushik JK; Batish VK
    Microbiol Res; 2014; 169(7-8):553-60. PubMed ID: 24332262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review.
    Insull W
    South Med J; 2006 Mar; 99(3):257-73. PubMed ID: 16553100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholesterol enhances membrane-damaging properties of model bile by increasing the intervesicular-intermixed micellar concentration of hydrophobic bile salts.
    Narain PK; DeMaria EJ; Heuman DM
    J Surg Res; 1999 Jun; 84(1):112-9. PubMed ID: 10334899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bile tolerance, taurocholate deconjugation, and binding of cholesterol by Lactobacillus gasseri strains.
    Usman ; Hosono A
    J Dairy Sci; 1999 Feb; 82(2):243-8. PubMed ID: 10068945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bile-mediated aminoglycoside sensitivity in Lactobacillus species likely results from increased membrane permeability attributable to cholic acid.
    Elkins CA; Mullis LB
    Appl Environ Microbiol; 2004 Dec; 70(12):7200-9. PubMed ID: 15574918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin-sensitive mechanism in murine and human hepatocytes.
    Dent P; Fang Y; Gupta S; Studer E; Mitchell C; Spiegel S; Hylemon PB
    Hepatology; 2005 Dec; 42(6):1291-9. PubMed ID: 16317705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probiotics--interactions with bile acids and impact on cholesterol metabolism.
    Pavlović N; Stankov K; Mikov M
    Appl Biochem Biotechnol; 2012 Dec; 168(7):1880-95. PubMed ID: 23054820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypocholesterolemic effects of Lactobacillus plantarum KCTC3928 by increased bile acid excretion in C57BL/6 mice.
    Jeun J; Kim S; Cho SY; Jun HJ; Park HJ; Seo JG; Chung MJ; Lee SJ
    Nutrition; 2010 Mar; 26(3):321-30. PubMed ID: 19695834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orally delivered microencapsulated live probiotic formulation lowers serum lipids in hypercholesterolemic hamsters.
    Bhathena J; Martoni C; Kulamarva A; Urbanska AM; Malhotra M; Prakash S
    J Med Food; 2009 Apr; 12(2):310-9. PubMed ID: 19459731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Progress in the effect of probiotics on cholesterol and its mechanism].
    Zhao JR; Yang H
    Wei Sheng Wu Xue Bao; 2005 Apr; 45(2):315-9. PubMed ID: 15989285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bile acid sequestrants: their use in combination with other lipid-lowering agents.
    Mandeville WH; Arbeeny C
    IDrugs; 1999 Mar; 2(3):237-42. PubMed ID: 16160934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feedback regulation of bile acid synthesis in primary human hepatocytes: evidence that CDCA is the strongest inhibitor.
    Ellis E; Axelson M; Abrahamsson A; Eggertsen G; Thörne A; Nowak G; Ericzon BG; Björkhem I; Einarsson C
    Hepatology; 2003 Oct; 38(4):930-8. PubMed ID: 14512880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lactobacillus plantarum CUL66 can impact cholesterol homeostasis in Caco-2 enterocytes.
    Michael DR; Moss JW; Calvente DL; Garaiova I; Plummer SF; Ramji DP
    Benef Microbes; 2016 Jun; 7(3):443-51. PubMed ID: 26839071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colesevelam hydrochloride: usefulness of a specifically engineered bile acid sequestrant for lowering LDL-cholesterol.
    Corsini A; Windler E; Farnier M
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):1-9. PubMed ID: 19237992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lactobacillus plantarum CECT 7527, 7528 and 7529: probiotic candidates to reduce cholesterol levels.
    Bosch M; Fuentes MC; Audivert S; Bonachera MA; Peiró S; Cuñé J
    J Sci Food Agric; 2014 Mar; 94(4):803-9. PubMed ID: 24186773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.